tradingkey.logo
tradingkey.logo

Revvity Inc

RVTY
104.430USD
+2.720+2.67%
終値 01/09, 16:00ET15分遅れの株価
11.91B時価総額
52.48直近12ヶ月PER

Revvity Inc

104.430
+2.720+2.67%

詳細情報 Revvity Inc 企業名

Revvity, Inc. is a provider of health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. The Company has specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more. Its segments include Life Sciences and Diagnostics. The Life Sciences segment provides products and services targeted towards the life sciences market. The segment offers instruments, reagents, software, detection and imaging technologies, and others. The Diagnostics segment develops diagnostics, tools, and applications focused on clinically oriented customers, within the reproductive health, immunodiagnostics, and applied genomics markets. The segment offers instruments, reagents, assay platforms and software to hospitals, medical labs, clinicians and medical research professionals to help improve the health of families.

Revvity Incの企業情報

企業コードRVTY
会社名Revvity Inc
上場日Aug 12, 2101
最高経営責任者「CEO」Singh (Prahlad R)
従業員数11000
証券種類Ordinary Share
決算期末Aug 12
本社所在地77 4Th Avenue
都市WALTHAM
証券取引所NASDAQ OMX NASDAQ Basic NYSE
United States of America
郵便番号02451
電話番号17816636900
ウェブサイトhttps://www.revvity.com/
企業コードRVTY
上場日Aug 12, 2101
最高経営責任者「CEO」Singh (Prahlad R)

Revvity Incの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Prahlad R. Singh, Ph.D.
Dr. Prahlad R. Singh, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
96.84K
-9420.00%
Mr. Alexandros P. (Alexis) Michas
Mr. Alexandros P. (Alexis) Michas
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
45.44K
+2840.00%
Mr. Joel S. Goldberg
Mr. Joel S. Goldberg
Senior Vice President - Administration, General Counsel, Secretary
Senior Vice President - Administration, General Counsel, Secretary
37.69K
+4289.00%
Dr. Peter Barrett, Ph.D.
Dr. Peter Barrett, Ph.D.
Independent Director
Independent Director
26.01K
+2412.00%
Mr. Maxwell Krakowiak
Mr. Maxwell Krakowiak
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
22.80K
-559.00%
Ms. Miriame Victor
Ms. Miriame Victor
Chief Commercial Officer, Senior Vice President
Chief Commercial Officer, Senior Vice President
14.29K
+5454.00%
Ms. Pascale Witz
Ms. Pascale Witz
Independent Director
Independent Director
13.71K
+2412.00%
Mr. Tajinder S. Vohra
Mr. Tajinder S. Vohra
Senior Vice President - Global Operations
Senior Vice President - Global Operations
10.44K
-12183.00%
Mr. Michael A. Klobuchar
Mr. Michael A. Klobuchar
Independent Director
Independent Director
5.09K
+2412.00%
Dr. Sophie V. Vandebroek, Ph.D.
Dr. Sophie V. Vandebroek, Ph.D.
Independent Director
Independent Director
5.09K
+2412.00%
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Prahlad R. Singh, Ph.D.
Dr. Prahlad R. Singh, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
96.84K
-9420.00%
Mr. Alexandros P. (Alexis) Michas
Mr. Alexandros P. (Alexis) Michas
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
45.44K
+2840.00%
Mr. Joel S. Goldberg
Mr. Joel S. Goldberg
Senior Vice President - Administration, General Counsel, Secretary
Senior Vice President - Administration, General Counsel, Secretary
37.69K
+4289.00%
Dr. Peter Barrett, Ph.D.
Dr. Peter Barrett, Ph.D.
Independent Director
Independent Director
26.01K
+2412.00%
Mr. Maxwell Krakowiak
Mr. Maxwell Krakowiak
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
22.80K
-559.00%
Ms. Miriame Victor
Ms. Miriame Victor
Chief Commercial Officer, Senior Vice President
Chief Commercial Officer, Senior Vice President
14.29K
+5454.00%

収益内訳

FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
FY2018
会社から関連データがまだ開示されていません。
地域別USD
会社名
収益
比率
Americas
509.67M
0.00%
Europe
391.67M
0.00%
Asia
189.28M
0.00%
事業別
地域別
会社から関連データがまだ開示されていません。

株主

更新時刻: Mon, Nov 17
更新時刻: Mon, Nov 17
株主統計
種類
株主統計
株主統計
比率
T. Rowe Price Investment Management, Inc.
19.85%
The Vanguard Group, Inc.
11.88%
EdgePoint Investment Group Inc.
7.56%
T. Rowe Price Associates, Inc.
7.05%
Janus Henderson Investors
6.73%
他の
46.93%
株主統計
株主統計
比率
T. Rowe Price Investment Management, Inc.
19.85%
The Vanguard Group, Inc.
11.88%
EdgePoint Investment Group Inc.
7.56%
T. Rowe Price Associates, Inc.
7.05%
Janus Henderson Investors
6.73%
他の
46.93%
種類
株主統計
比率
Investment Advisor
69.87%
Investment Advisor/Hedge Fund
25.81%
Hedge Fund
2.79%
Pension Fund
1.77%
Research Firm
1.69%
Sovereign Wealth Fund
1.18%
Bank and Trust
1.07%
Individual Investor
0.30%
Family Office
0.05%

機関投資家保有株

更新時刻: Thu, Jan 1
更新時刻: Thu, Jan 1
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q4
1149
118.27M
104.32%
-7.85M
2025Q3
1177
117.06M
100.85%
-8.83M
2025Q2
1199
113.79M
98.03%
-7.04M
2025Q1
1255
117.73M
99.83%
-3.82M
2024Q4
1277
114.54M
95.28%
-3.97M
2024Q3
1253
112.35M
91.11%
-5.77M
2024Q2
1249
112.44M
91.13%
-1.63M
2024Q1
1287
107.57M
87.09%
-8.24M
2023Q4
1315
109.29M
88.55%
-2.41M
2023Q3
1347
106.10M
85.47%
-6.10M
詳細を見る

株主動向

会社名
保有株式数
比率
変動額
変動率
日付
T. Rowe Price Investment Management, Inc.
22.50M
19.85%
-140.67K
-0.62%
Sep 30, 2025
The Vanguard Group, Inc.
13.47M
11.88%
-564.06K
-4.02%
Sep 30, 2025
EdgePoint Investment Group Inc.
8.57M
7.56%
+1.78M
+26.28%
Sep 30, 2025
T. Rowe Price Associates, Inc.
8.00M
7.05%
+196.30K
+2.52%
Sep 30, 2025
Janus Henderson Investors
7.63M
6.73%
+405.54K
+5.62%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
6.04M
5.33%
+229.56K
+3.95%
Sep 30, 2025
State Street Investment Management (US)
4.95M
4.36%
-71.58K
-1.43%
Sep 30, 2025
Geode Capital Management, L.L.C.
2.96M
2.61%
-16.67K
-0.56%
Sep 30, 2025
Invesco Capital Management LLC
2.26M
1.99%
+317.90K
+16.41%
Sep 30, 2025
UBS Financial Services, Inc.
2.14M
1.89%
+393.77K
+22.49%
Sep 30, 2025
詳細を見る

関連ETF

更新時刻: Sat, Dec 6
更新時刻: Sat, Dec 6
銘柄名
比率
First Trust Indxx Medical Devices ETF
2.12%
Invesco S&P 500 Equal Weight Health Care ETF
1.85%
T Rowe Price Capital Appreciation Equity ETF
1.36%
Simplify Health Care ETF
1.29%
ROBO Global Healthcare Technology & Innovation ETF
1.16%
First Trust Health Care Alphadex Fund
0.93%
Pacer CFRA-Stovall Equal Weight Seasonal Rot Idx
0.84%
VanEck Morningstar SMID Moat ETF
0.64%
Neuberger Berman Small-Mid Cap ETF
0.56%
NYLI Candriam US Mid Cap Equity ETF
0.5%
詳細を見る
First Trust Indxx Medical Devices ETF
比率2.12%
Invesco S&P 500 Equal Weight Health Care ETF
比率1.85%
T Rowe Price Capital Appreciation Equity ETF
比率1.36%
Simplify Health Care ETF
比率1.29%
ROBO Global Healthcare Technology & Innovation ETF
比率1.16%
First Trust Health Care Alphadex Fund
比率0.93%
Pacer CFRA-Stovall Equal Weight Seasonal Rot Idx
比率0.84%
VanEck Morningstar SMID Moat ETF
比率0.64%
Neuberger Berman Small-Mid Cap ETF
比率0.56%
NYLI Candriam US Mid Cap Equity ETF
比率0.5%

配当金

過去5年間の配当金総支払額は 137.14M 米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
Oct 23, 2025
RVTY.NB Final Cash Dividend of gross USD 0.07 paid on Feb 06, 2026 going ex on Jan 16, 2026
Jan 16, 2026
Feb 06, 2026
Jan 16, 2026
Jul 24, 2025
RVTY.NB Interim Cash Dividend of gross USD 0.07 paid on Nov 07, 2025 going ex on Oct 17, 2025
Oct 17, 2025
Nov 07, 2025
Oct 17, 2025
Apr 24, 2025
RVTY.NB Interim Cash Dividend of gross USD 0.07 paid on Aug 08, 2025 going ex on Jul 18, 2025
Jul 18, 2025
Aug 08, 2025
Jul 18, 2025
Jan 23, 2025
RVTY.NB Interim Cash Dividend of gross USD 0.07 paid on May 09, 2025 going ex on Apr 17, 2025
Apr 18, 2025
May 09, 2025
Apr 17, 2025
Oct 24, 2024
RVTY.NB Final Cash Dividend of gross USD 0.07 paid on Feb 07, 2025 going ex on Jan 17, 2025
Jan 17, 2025
Feb 07, 2025
Jan 17, 2025
Jul 25, 2024
RVTY.NB Final Cash Dividend of gross USD 0.07 paid on Nov 08, 2024 going ex on Oct 18, 2024
Oct 18, 2024
Nov 08, 2024
Oct 18, 2024
Apr 25, 2024
RVTY.NB Interim Cash Dividend of gross USD 0.07 paid on Aug 09, 2024 going ex on Jul 19, 2024
Jul 19, 2024
Aug 09, 2024
Jul 19, 2024
Jan 25, 2024
RVTY.NB Interim Cash Dividend of gross USD 0.07 paid on May 10, 2024 going ex on Apr 18, 2024
Apr 19, 2024
May 10, 2024
Apr 18, 2024
Oct 26, 2023
RVTY.NB Interim Cash Dividend of gross USD 0.07 paid on Feb 09, 2024 going ex on Jan 18, 2024
Jan 19, 2024
Feb 09, 2024
Jan 18, 2024
Jul 21, 2023
RVTY.NB Final Cash Dividend of gross USD 0.07 paid on Nov 10, 2023 going ex on Oct 19, 2023
Oct 20, 2023
Nov 10, 2023
Oct 19, 2023
詳細を見る

株式分割

日付
種類
比率
データなし
日付
種類
比率
データなし

よくある質問

Revvity Incの上位5名の株主は誰ですか?

Revvity Incの上位5名の株主は以下のとおりです。
T. Rowe Price Investment Management, Inc.は22.50M株を保有しており、これは全体の19.85%に相当します。
The Vanguard Group, Inc.は13.47M株を保有しており、これは全体の11.88%に相当します。
EdgePoint Investment Group Inc.は8.57M株を保有しており、これは全体の7.56%に相当します。
T. Rowe Price Associates, Inc.は8.00M株を保有しており、これは全体の7.05%に相当します。
Janus Henderson Investorsは7.63M株を保有しており、これは全体の6.73%に相当します。

Revvity Incの株主タイプ上位3種は何ですか?

Revvity Incの株主タイプ上位3種は、
T. Rowe Price Investment Management, Inc.
The Vanguard Group, Inc.
EdgePoint Investment Group Inc.

Revvity Inc(RVTY)の株式を保有している機関の数はいくつですか?

2025Q4時点で、Revvity Incの株式を保有している機関は1149社あり、保有株式の総市場価値は約118.27Mで、全体の104.32%を占めています。2025Q3と比較して、機関の持ち株は3.47%増加しています。

Revvity Incの最大の収益源は何ですか?

FY2025Q3において、--部門がRevvity Incにとって最大の収益を生み出しており、その金額は--で、全収益の--%を占めています。
KeyAI